NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


Don't have an account? Subscribe

Treating acne and rosacea in patients with skin of colour

By Mindo - 13th Mar 2019

Prof Jerry Tan highlighted the challenges in treating acne and rosacea in patients with skin of colour at the PCDSI annual meeting in Galway recently.

Making a diagnosis is challenging due to the modifying effect of pigment against underlying inflammation. Management can also prove difficult due to the post-inflammatory or macular hyperpigmentation, Prof Tan told delegates.

It is almost impossible to see red against a darker background, which is why patients should be questioned about pain, heat and swelling during consultations, he recommended.

Spectral subtraction imaging (RBX) is used for patients with skin of colour who have acne, including when making a decision on when to stop isotretinoin, Prof Tan explained.

The tool has proved highly beneficial in acne diagnosis and management, as in the past there was a widely-held view that rosacea did not exist among Asian patients, Prof Tan revealed.

RBX allows clinicians to see what is below the skin and, therefore, enables doctors to treat the condition effectively, he explained.

In a separate talk on acne in the adult female, GP Dr Johnny Loughnane revealed that the condition has become more common in recent times.

In 80 per cent of cases, post-adolescent female acne fails to respond to conventional therapy. Furthermore, such cases involve a 30 per cent relapse rate with isotretinoin treatment, he noted.

Hormonal treatment is the most effective agent for adult female acne, he advised, but a positive response to treatment can take up to six months.

He provided an overview of acne in pregnancy, severe acne in females, the advantages and disadvantages of different hormone regimens, and spironolactone as a treatment option.

Leave a Reply

Latest
Latest Issue
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read